Dr James Gardner Internal Medicine | |
1133 College Ave Suite D200 Manhattan KS 66502-2770 | |
(785) 537-4940 | |
(785) 537-0836 |
Full Name | Dr James Gardner Internal Medicine |
---|---|
Speciality | Clinic/center - Primary Care |
Location | 1133 College Ave, Manhattan, Kansas |
Authorized Official Name and Position | James Dixon Gardner (CEO) |
Authorized Official Contact | 7855374940 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Dr James Gardner Internal Medicine 1133 College Ave Suite D200 Manhattan KS 66502-2770 Ph: (785) 537-4940 | Dr James Gardner Internal Medicine 1133 College Ave Suite D200 Manhattan KS 66502-2770 Ph: (785) 537-4940 |
NPI Number | 1013315209 |
---|---|
Provider Enumeration Date | 12/20/2014 |
Last Update Date | 12/20/2014 |
Identifier | Type | State | Issuer |
---|---|---|---|
1013315209 | NPI | - | NPPES |
480839957 | Other | KS | OLD TAX ID FROM OLD PRACTICE ENDED 12/31/2014 |
1497718092 | Other | KS | PHYSICIAN NPI NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QP2300X | Clinic/center - Primary Care | 0416479 (Kansas) | Primary |
News Archive
The discovery of tri-specific natural killer engagers (TriKEā¢), a combination protein that bridges an immune cell and a tumor cell to drive tumor cell killing power exponentially, has led to a new Phase I, first-in-human study to treat leukemia.
Food and Drug Administration officials in the U.S. have announced that two prescription creams to treat eczema will now carry strong warnings about the possible risk of skin cancer, lymphoma and other cancers.
A report published last week that found three researchers from Harvard Medical School were "vastly underreporting their income from drug companies" offers "striking proof that today's requirements for reporting payments from industry - essentially an honor system in which researchers are supposed to reveal their outside income to their institutions" - must "be strengthened," a New York Times editorial states.
A.P. Pharma, Inc. has announced that it has submitted a New Drug Application (NDA) for its lead product, APF530, to the U.S. Food and Drug Administration (FDA). APF530 is being developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) and is a long-acting formulation of granisetron that utilizes the Company's proprietary Biochronomer drug delivery system.
› Verified 2 days ago
Smith Internal Medicine, P.a. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3260 Kimball Ave, Manhattan, KS 66503 Phone: 785-539-0800 Fax: 785-539-0811 | |
Matthew W Floersch, M.d., Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1133 College Ave, Suite C-143, Manhattan, KS 66502 Phone: 785-537-4940 Fax: 785-537-0836 | |
Stonecreek Family Physicians, Llp Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4101 Anderson Ave, Manhattan, KS 66503 Phone: 785-587-4101 Fax: 785-587-9090 | |
Manhattan Primary Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1133 College Ave, Bldg A, Suite 211, Manhattan, KS 66502 Phone: 913-642-4900 Fax: 913-381-0979 | |
Primary Care Physicians Of Manhattan Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1133 College Ave, Suite C-143, Manhattan, KS 66502 Phone: 785-537-4940 Fax: 785-537-0836 | |
Midwest Prompt Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3258 Kimball Ave, Manhattan, KS 66503 Phone: 785-539-0800 Fax: 785-539-0811 |